Literature DB >> 26165564

Determining the safety of microbial cultures for consumption by humans and animals.

Michael W Pariza1, Kevin O Gillies2, Sarah F Kraak-Ripple3, Gregory Leyer4, Amy B Smith3.   

Abstract

Fermented foods and feeds have been consumed for millennia, and microorganisms isolated from traditional fermentations have been used as probiotics. There is interest in developing new microbial cultures for these uses, but to date safety evaluation procedures have only been discussed in general terms. We propose a comprehensive approach for determining the safety of microbial cultures that lack an established history of safe use for their intended new applications. Three scenarios are considered: (1) substantially increased exposure to a culture that has an established record of safety in a more limited application; (2) a new strain without a history of safe use that was isolated from a food or feed that has a history of safe use; and (3) a new strain isolated from a non-food or non-feed source. Our safety evaluation process is based on scientific procedures and is in the form of a decision tree composed of 13 questions. Our decision tree for determining the safety of microbial cultures for consumption by humans or animals is modeled on previous decision trees that are used worldwide to evaluate the safety of microbial enzymes for use in human food or animal feed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fermented feed; Fermented food; Food safety; Microbial culture safety; Probiotic safety; Safety decision tree; Safety evaluation

Mesh:

Year:  2015        PMID: 26165564     DOI: 10.1016/j.yrtph.2015.07.003

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  17 in total

1.  The qualified presumption of safety assessment and its role in EFSA risk evaluations: 15 years past.

Authors:  Lieve Herman; Marianne Chemaly; Pier Sandro Cocconcelli; Pablo Fernandez; Günter Klein; Luisa Peixe; Miguel Prieto; Amparo Querol; Juan Evaristo Suarez; Ingvar Sundh; Just Vlak; Sandra Correia
Journal:  FEMS Microbiol Lett       Date:  2019-10-01       Impact factor: 2.742

2.  Safety Evaluation of Lactobacillus delbrueckii subsp. lactis CIDCA 133: a Health-Promoting Bacteria.

Authors:  Luís Cláudio Lima de Jesus; Thiago de Jesus Sousa; Flávia Figueira Aburjaile; Vasco Azevedo; Nina Dias Coelho-Rocha; Rodrigo Profeta; Fernanda Alvarenga Lima Barroso; Mariana Martins Drumond; Pamela Mancha-Agresti; Ênio Ferreira; Bertram Brenig
Journal:  Probiotics Antimicrob Proteins       Date:  2021-08-17       Impact factor: 5.265

3.  Genotyping by PCR and High-Throughput Sequencing of Commercial Probiotic Products Reveals Composition Biases.

Authors:  Wesley Morovic; Ashley A Hibberd; Bryan Zabel; Rodolphe Barrangou; Buffy Stahl
Journal:  Front Microbiol       Date:  2016-11-03       Impact factor: 5.640

Review 4.  Regulatory and Safety Requirements for Food Cultures.

Authors:  Svend Laulund; Anette Wind; Patrick M F Derkx; Véronique Zuliani
Journal:  Microorganisms       Date:  2017-05-23

5.  Safety Assessment of a Nham Starter Culture Lactobacillus plantarum BCC9546 via Whole-genome Analysis.

Authors:  Nipa Chokesajjawatee; Pannita Santiyanont; Kanittha Chantarasakha; Kanokarn Kocharin; Chinae Thammarongtham; Supatcha Lertampaiporn; Tayvich Vorapreeda; Tanawut Srisuk; Thidathip Wongsurawat; Piroon Jenjaroenpun; Intawat Nookaew; Wonnop Visessanguan
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

6.  The qualified presumption of safety assessment and its role in EFSA risk evaluations: 15 years past.

Authors:  Lieve Herman; Marianne Chemaly; Pier Sandro Cocconcelli; Pablo Fernandez; Günter Klein; Luisa Peixe; Miguel Prieto; Amparo Querol; Juan Evaristo Suarez; Ingvar Sundh; Just Vlak; Sandra Correia
Journal:  FEMS Microbiol Lett       Date:  2019-01-01       Impact factor: 2.742

7.  Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial.

Authors:  Christopher J Martoni; Malkanthi Evans; Cheryl-Emiliane T Chow; Luisa S Chan; Gregory Leyer
Journal:  J Dig Dis       Date:  2019-08-01       Impact factor: 2.325

8.  Representative Bacillus sp. AM1 from Gut Microbiota Harbor Versatile Molecular Pathways for Bisphenol A Biodegradation.

Authors:  Ana López-Moreno; Alfonso Torres-Sánchez; Inmaculada Acuña; Antonio Suárez; Margarita Aguilera
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

9.  Toxicological safety evaluation of live Anaerobutyricum soehngenii strain CH106.

Authors:  Jos F M L Seegers; Ismail Sahin Gül; Stijn Hofkens; Sonja Brosel; Gudrun Schreib; Jara Brenke; Claudia Donath; Willem M de Vos
Journal:  J Appl Toxicol       Date:  2021-06-29       Impact factor: 3.628

10.  Isolation and characterization of a Bacillus amyloliquefaciens strain with zearalenone removal ability and its probiotic potential.

Authors:  An Lee; Kuan-Chen Cheng; Je-Ruei Liu
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.